Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells
2007

How pRb Inactivation Causes Antiestrogen Resistance in Breast Cancer Cells

publication 10 minutes Evidence: moderate

Author Information

Author(s): Varma Hemant, Skildum Andrew J., Conrad Susan E.

Primary Institution: Michigan State University

Hypothesis

The study investigates the mechanism by which pRb inactivation leads to antiestrogen resistance in breast cancer cells.

Conclusion

Inactivation of pRb leads to increased cdk2 activity and proliferation in antiestrogen-arrested breast cancer cells.

Supporting Evidence

  • Inactivation of pRb leads to increased cyclin A expression and cdk2 activation.
  • Cells lacking functional pRb do not require cdk4 activity for proliferation.
  • Antiestrogens do not inhibit cdk2 activity in the absence of pRb function.

Takeaway

When a certain protein (pRb) is turned off in breast cancer cells, the cells can grow even when treated with drugs that usually stop their growth.

Methodology

The study used MCF-7 breast cancer cells and tested the effects of pRb inactivation on cell proliferation and cdk activity.

Limitations

The study primarily used a single cell line (MCF-7) and results may not be generalizable to all breast cancer types.

Digital Object Identifier (DOI)

10.1371/journal.pone.0001256

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication